The typical modern laboratory is crammed with electronic equipment of various ages and complexity, all using different software and reporting formats. 

Risk assessors face increasing demands to assess more chemicals, with greater speed and accuracy, and at the same time use fewer resources ...

We are pleased to announce the new release of EdelweissData™ DataExplorer 

When chemicals injure cells, that injury initiates response pathways that signal stress in the cells. The strong activation of these pathways signals the onset of toxicity.

Our new platform, EdelweissData™, makes data management, integration and sharing easy. Simply upload your files - in any form - directly onto our secure, cloud-based platform.

Paul Jennings, Head of Molecular and Computational Toxicology at the Vrije Universiteit Amsterdam, on research data management.

Some of our most powerful modern pharmaceuticals come from nature. Yet, less than 10% of the 250,000 known plant species have been studied ...

More accurate, reproducible risk assessment to determine whether a substance is a skin sensitiser

Managing Director of Douglas Connect, Barry Hardy, and Scientific Project Manager Lucian Farcal are among the international authors.

Get the right people talking together about a problem and you might come up with a new approach, if not a solution.

On May 7-11, Douglas Connect relaunches its own InnovationWell Knowledge Cafés, with three events. The three events are designed to draw scientists from industry, academia and government agencies and the general public to the same table. 

Douglas Connect, known for its focus on collaboration and community, offered its visitors a session of free data counselling.

Why would a busy CEO give time to starting a global, public-benefit organization? For that matter, how do you even go about it? 

The most important resource for an empirical science like toxicology and its application in risk assessment is data... 

Douglas Connect's Senior Software Engineer Daniel Bachler recently gave this talk at the GOTO Berlin 2017 Conference.

One of the main messages of the Global Summit on Regulatory Science (GSRS17) held in Brasilia in September was that decision-making about safety assessment is undergoing a major transition.

Miracle cures were just around the corner. After a few years, when the miracles didn’t appear, a period of popular disillusion set in.

Sometimes we forget that science is about people. And how one conversation can define a solution or take research in a new direction.

Every day, we come into contact with chemicals whose effects on the human body and the environment have not been adequately tested. Over 100,000 of them need urgent evaluation  ...